insulin

News
chessboard with two knights facing each other

FTC sues PBMs over 'perverse' rebate system

The Federal Trade Commission (FTC) has sued the top three pharmacy benefit managers (PBMs) in the US for operating a "perverse drug rebate system" that it claims artificially inflated the p

R&D
pharmaphorum podcast episode 83
Sponsored

Insulin costs & pharma manufacturing

While the pharma press often focuses on R&D and drug development, the actual manufacture of drugs is an interesting space in its own right that drives many of the trends in drug pricing